v3.25.2
EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE
9 Months Ended
Jun. 30, 2025
Equity Method Investments and Joint Ventures [Abstract]  
EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE
As discussed in Note 5, the Company completed the divestiture of a majority stake in Copeland on May 31, 2023, and received upfront, pretax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion, while retaining a 40 percent non-controlling common equity interest in Copeland.

On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and the note receivable to Copeland for $1.9 billion, and the transactions were subsequently completed in August 2024.
For the three and nine months ended June 30, 2024 the Company recognized non-cash interest income on the note receivable (through the date of the agreement) of $24 and $86, respectively which is reported in Interest income from related party within continuing operations. Upon entering into the note agreement, the Company recorded a pretax loss of $279 ($217 after-tax, $0.38 per share) to adjust the carrying value of the note to $1.9 billion to reflect the transaction price.
Summarized financial information for Copeland for the three and nine months ended June 30, 2024 is as follows.
 Three Months Ended June 30,Nine Months Ended June 30,
 2024 2024 
Net sales $1,259 $3,458 
Gross profit$441 $1,198 
Income (loss) from continuing operations$(40)$(280)
Net income (loss)$(40)$(280)
Net income (loss) attributable to shareholders$(40)$(278)